2024
DOI: 10.3390/biomedicines12030520
|View full text |Cite
|
Sign up to set email alerts
|

Pathophysiology-Based Management of Secondary Injuries and Insults in TBI

Leonardo de Macedo Filho,
Luisa F. Figueredo,
Gustavo Adolfo Villegas-Gomez
et al.

Abstract: Traumatic Brain Injury (TBI) remains a leading cause of morbidity and mortality among all ages; despite the advances, understanding pathophysiological responses after TBI is still complex, involving multiple mechanisms. Previous reviews have focused on potential targets; however, the research on potential targets has continuously grown in the last five years, bringing even more alternatives and elucidating previous mechanisms. Knowing the key and updated pathophysiology concepts is vital for adequate managemen… Show more

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(2 citation statements)
references
References 131 publications
(213 reference statements)
0
2
0
Order By: Relevance
“…Altogether, the present findings highlight the potential of blood-brain barrier-derived biomarkers to also assess and monitor the clinical course of traumatic brain injuries in humans. Specifically, we here addressed the diffuse secondary disease progression of acceleration/deceleration injuries that is particularly difficult to capture [58]. Currently, blood-based biomarkers reflecting neuronal (i.e., ubiquitin carboxy-terminal hydrolase L1, UCH-L1) or astrocyte (i.e., glial fibrillary acidic protein, GFAP) have emerged, mostly differentiating more severe forms of TBI, but not (mild) concussion [59].…”
Section: Discussionmentioning
confidence: 99%
“…Altogether, the present findings highlight the potential of blood-brain barrier-derived biomarkers to also assess and monitor the clinical course of traumatic brain injuries in humans. Specifically, we here addressed the diffuse secondary disease progression of acceleration/deceleration injuries that is particularly difficult to capture [58]. Currently, blood-based biomarkers reflecting neuronal (i.e., ubiquitin carboxy-terminal hydrolase L1, UCH-L1) or astrocyte (i.e., glial fibrillary acidic protein, GFAP) have emerged, mostly differentiating more severe forms of TBI, but not (mild) concussion [59].…”
Section: Discussionmentioning
confidence: 99%
“…The pathophysiology of TBI has traditionally been divided into a primary injury and a secondary injury. The primary injury is caused by external direct mechanical insult, acceleration or deceleration forces, or penetrating objects causing focal and/or diffuse brain injury, including contusions, hemorrhages, and axonal injury ( de Macedo et al, 2024 ). Following primary injury to the brain, activation of a highly complex cascade of secondary events evolves simultaneously and interact to aggravate the primary brain injury ( Ng and Lee, 2019 ).…”
Section: The Pathophysiology Of Traumatic Brain Injurymentioning
confidence: 99%